N
Nat Lenzo
Researcher at University of Notre Dame
Publications - 59
Citations - 3028
Nat Lenzo is an academic researcher from University of Notre Dame. The author has contributed to research in topics: Prostate cancer & Positron emission tomography. The author has an hindex of 18, co-authored 54 publications receiving 2671 citations. Previous affiliations of Nat Lenzo include Edith Cowan University & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
Christopher C. Rowe,Kathryn A. Ellis,Kathryn A. Ellis,Miroslava Rimajova,Pierrick Bourgeat,Kerryn E. Pike,Gareth Jones,Jurgen Fripp,Henri Tochon-Danguy,Laurence Morandeau,Graeme O'Keefe,Roger I. Price,Parnesh Raniga,Peter Robins,Oscar Acosta,Nat Lenzo,Cassandra Szoeke,Olivier Salvado,Richard Head,Ralph N. Martins,Colin L. Masters,David Ames,Victor L. Villemagne +22 more
TL;DR: PiB binding in AD was unrelated to age, hippocampal volume or memory, and secondary factors or downstream events appear to play a more direct role than total beta amyloid burden in hippocampal atrophy and cognitive decline.
Journal ArticleDOI
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease
Kathryn A. Ellis,Ashley I. Bush,David Darby,Daniela De Fazio,Jonathan K. Foster,Peter Hudson,Nicola T. Lautenschlager,Nat Lenzo,Ralph N. Martins,Paul Maruff,Colin L. Masters,Andrew Milner,Kerryn E. Pike,Christopher C. Rowe,Greg Savage,Cassandra Szoeke,Kevin Taddei,Victor L. Villemagne,Michael Woodward,David Ames +19 more
TL;DR: The participants comprising the AIBL cohort represent a group of highly motivated and well-characterized individuals who represent a unique resource for the study of AD.
Journal ArticleDOI
Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy
Martyn A. French,Nat Lenzo,Mina John,Simon Mallal,Elizabeth McKinnon,Ian James,Patricia Price,James Flexman,M-L. Tay-Kearney +8 more
TL;DR: A single‐centre retrospective study of all HIV‐infected patients commencing HAART prior to 1 July 1997 was undertaken to determine the incidence, characteristics and time of onset of disease episodes in HAART responders.
Journal ArticleDOI
Hepatic steatosis and lactic acidosis associated with stavudine treatment in an HIV patient: a case report.
Journal ArticleDOI
Review of Gallium-68 PSMA PET/CT Imaging in the Management of Prostate Cancer.
TL;DR: 68Ga-PSMA is the diagnostic positron-emitting theranostic pair with the beta emitter Lutetium-177 PSMA and alpha-emitter Actinium-225 PSMA which can both be used to treat PSMA-avid metastases of prostate cancer in the molecular tumor-targeted approach of the Branostic nuclear oncology.